Mostrando 4 resultados de: 4
Blood Pressure Decrease during the Acute Phase of Ischemic Stroke Is Associated with Brain Injury and Poor Stroke Outcome
ArticleAbstract: Background and Purpose-Studies on the relation between blood pressure (BP) and stroke outcome have sPalabras claves:Blood pressure, Cerebral infarction, Hypertension, prognosis, strokeAutores:Blanco M., Castillo J., Dávalos A., Leira R., Serena J., Washington Stalin García CuentaFuentes:scopusIncreased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke
ArticleAbstract: BACKGROUND AND PURPOSE - Iron overload has been associated with greater oxidative stress and brain iPalabras claves:Ferritin, Iron overload, Ischemic stroke, outcome, Oxidative Stress, thrombolysisAutores:Arenillas J.F., Castellanos M., Castillo J., Cristobo I., Dávalos A., Millan M., Moro M.A., Nombela F., Riva E., Serena J., Sobrino T., Vivancos J., Washington Stalin García CuentaFuentes:scopusInflammation-mediated damage in progressing lacunar infarctions a potential therapeutic target
ArticleAbstract: Background and Purpose - The mechanisms underlying neurological deterioration in patients with lacunPalabras claves:cytokines, inflammation, Lacunar infarction, Stroke outcomeAutores:Castellanos M., Castillo J., Chamorro A., Dávalos A., Leira R., Serena J., Washington Stalin García CuentaFuentes:scopusSerum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the pbkp_rediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study
ArticleAbstract: BACKGROUND AND PURPOSE - Plasma levels of cellular fibronectin (c-Fn) ≥3.6 μg/mL and of matrix metalPalabras claves:Biomarkers, blood-brain barrier, hemorrhage, Metalloproteinases, stroke, Thrombolytic therapyAutores:Arenillas J.F., Brea D., Castellanos M., Castillo J., Dávalos A., Millan M., Nombela F., Perez De La Ossa N., Serena J., Sobrino T., Vivancos J., Washington Stalin García CuentaFuentes:scopus